Dorsal Capital Management’s Nutanix NTNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,300,000
Closed -$49.4M 30
2026
Q1
$49.4M Sell
1,300,000
-300,000
-19% -$12.6M 1.92% 19
2025
Q4
$82.7M Buy
1,600,000
+250,000
+19% +$15.3M 2.87% 15
2025
Q3
$100M Buy
1,350,000
+450,000
+50% +$33M 2.68% 17
2025
Q2
$68.8M Hold
900,000
1.83% 20
2025
Q1
$62.8M Buy
+900,000
New +$62.3M 1.92% 21
2019
Q1
Sell
-900,000
Closed -$37.4M 22
2018
Q4
$37.4M Buy
+900,000
New +$37.2M 2.62% 20

Other funds holding NTNX

Dorsal Capital Management's NTNX Position: Q2 2026 in Review

Dorsal Capital Management sold out of Nutanix (NTNX) in Q2 2026, closing a stake of 1,300,000 shares — an estimated $49.4M sold.

Dorsal Capital Management first reported a position in NTNX in Q4 2018 and held it in 6 quarters. The position peaked at $100M in Q3 2025. 564 funds tracked by Wall St. Rank hold NTNX as of Q2 2026.

  • Dorsal Capital Management reported no remaining Nutanix position as of Q2 2026 after selling out during the quarter.
  • Dorsal Capital Management sold 1,300,000 Nutanix shares in Q2 2026, an estimated $49.4M.
  • Dorsal Capital Management first reported a position in Nutanix in Q4 2018 and held it in 6 quarters.
  • Dorsal Capital Management's Nutanix position peaked at $100M in Q3 2025.
  • 564 funds tracked by Wall St. Rank held Nutanix as of Q2 2026.

Based on Dorsal Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.